Lmcg Investments, LLC Repligen Corp Transaction History

Lmcg Investments, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$120.0 - $182.95 $3,720 - $5,671	-31 Reduced 0.88%	3,507 $442,000
Q1 2024 May 03, 2024	SELL	$170.78 - $208.42 $258,902 - $315,964	-1,516 Reduced 30.0%	3,538 $650,000
Q3 2023 Nov 02, 2023	BUY	$138.78 - $176.51 $298,793 - $380,026	2,153 Added 74.22%	5,054 $803,000
Q1 2023 May 04, 2023	BUY	$154.26 - $198.1 $10,335 - $13,272	67 Added 2.36%	2,901 $488,000
Q4 2022 Feb 06, 2023	BUY	$162.42 - $220.56 $974 - $1,323	6 Added 0.21%	2,834 $479,000
Q3 2022 Nov 07, 2022	BUY	$160.42 - $256.21 $6,256 - $9,992	39 Added 1.4%	2,828 $529,000
Q1 2022 May 10, 2022	BUY	$161.19 - $257.96 $449,558 - $719,450	2,789 New	2,789 $525,000

476

55.6M

311K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.09B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Lmcg Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Lmcg Investments, LLC with notifications on news.